Cosmos Holdings Inc. (NASDAQ COSM) – Fundamental Analysis


Cosmos Holdings Inc. (NASDAQ COSM) is engaged in the research, development, and commercialization of pharmaceutical products and medicines across the European Union member states. It offers over-the-counter drugs and branded and generic medicines. The company’s focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, and wholesalers and retail healthcare providers.

7 Top Reasons To Get Cosmos Holdings On Your Radar Now

– The company just released important financial news where they achieved $3.3 million of adjusted EBITDA for the fiscal year 2021 and a 134% increase in adjusted net income.

– The company’s Greece located pharmaceutical logistic center, CosmoFarm, just got a major facelift with the integration of an SSI SCHAEFER’s A-Frame Automated Robotic Picking System.

– According to Fortune Business Insights, the health scare in 2020 “accelerated the demand for effective treatments and dr-ugs worldwide” and caused the global pharmaceutical industry to reach an estimated valuation of $1.3 Trillion.

– Cosmos has an extensive network of over 160 clients and vendors in Germany, the United Kingdom, The United Arab Emirates, Denmark, Italy, France, Singapore, Ireland, Sweden, Poland, Netherlands, and Greece.

– The foundation of Cosmos’ operating strategy is the optimization and growth of its pharmaceutical sourcing and distribution businesses. On the other hand, its sourcing and distribution, including specialty pharmaceuticals, is what Cosmos sees as the anchor of its development and position in the pharmaceutical supply channel.

– Not only did Cosmos see 2020 revenue growth of about 40% and jaw-dropping gross profit growth of nearly 120%,(9) it reported 15.8% year-over-year growth and a 27.8% sequential increase in revenue for Q2 2021.

– Cosmos Holdings recently announced closing of $6 Million private placement

Discover why Cosmos Holdings Become a Major Disruptor in an Estimated $1.3 Trillion Global Pharma Industry. This is the perfect add to watch-list stock and do your due diligence.

This business has huge potential, so check out this article for a further analysis on the company.

https://innovativehealthreport.com/global-demand-for-medication/?utm_source=dmreddit2&utm_medium=affiliate&utm_campaign=cosmz_us

Disclaimer: “This User has been paid $200USD by a third party to provide coverage on 02/16-20/2022 for Cosmos Holdings Inc. (COSM).”


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *